Whole brain radiotherapy for brain metastases from non-small cell lung cancer: the end of an era?
- PMID: 28066650
- PMCID: PMC5179392
- DOI: 10.21037/jtd.2016.11.41
Whole brain radiotherapy for brain metastases from non-small cell lung cancer: the end of an era?
Conflict of interest statement
The authors have no conflicts of interest to declare.
Comment on
-
Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial.Lancet. 2016 Oct 22;388(10055):2004-2014. doi: 10.1016/S0140-6736(16)30825-X. Epub 2016 Sep 4. Lancet. 2016. PMID: 27604504 Free PMC article. Clinical Trial.
References
-
- Law A, Karp DD, Dipetrillo T, et al. Emergence of increased cerebral metastasis after high-dose preoperative radiotherapy with chemotherapy in patients with locally advanced nonsmall cell lung carcinoma. Cancer 2001;92:160-4. 10.1002/1097-0142(20010701)92:1<160::AID-CNCR1304>3.0.CO;2-X - DOI - PubMed
-
- Mulvenna P, Nankivell M, Barton R, et al. Dexamethasone and supportive care with or without whole brain radiotherapy in treating patients with non-small cell lung cancer with brain metastases unsuitable for resection or stereotactic radiotherapy (QUARTZ): results from a phase 3, non-inferiority, randomised trial. Lancet 2016;388:2004-2014. 10.1016/S0140-6736(16)30825-X - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources